The information contained in this news report may not be published, broadcast or otherwise distributed without the prior written authority of Globe Newswire, Inc.
The glucagon receptor agonism is thought to play an important role in hepatic fat reduction: preclinical and early clinical data suggest that glucagon stimulates hepatic fatty acid oxidation and promotes lipid export from the liver, potentially reducing intrahepatic triglyceride content
Ozempic, a semaglutide-based GLP-1 receptor agonist, has become one of the most recognized medications for weight management and blood sugar control
Results vary by individual based on goals, lifestyle, and medical conditions
If you want to understand your individual response to GLP-1 therapy and optimize outcomes, the Precision Peptide Genetic Test ($99 add-on after your first month) maps 14 metabolic pathways and 49 peptides to reveal how variants like FTO rs9939609 and MC4R rs17782313 may affect your weight loss trajectory